Page last updated: 2024-08-23

substance p and Carcinoma, Ovarian Epithelial

substance p has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Afshari, AR; AlAlikhan, A; Ghahremanloo, A; Hashemy, SI; Javid, H; Momen Razmgah, M	1

Other Studies

1 other study(ies) available for substance p and Carcinoma, Ovarian Epithelial

Article	Year
The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells. Molecular biology reports, 2022, Volume: 49, Issue:10 Topics: Aprepitant; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Ovarian Neoplasms; Receptors, Neurokinin-1; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Substance P; Vascular Endothelial Growth Factor A	2022

Article

Year

The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.

Molecular biology reports, 2022, Volume: 49, Issue:10

Topics: Aprepitant; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Ovarian Neoplasms; Receptors, Neurokinin-1; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Substance P; Vascular Endothelial Growth Factor A

2022